James L. Grainer has served as Chief Financial Officer of Gene Biotherapeutics since May 2020, and also currently serves as the Chief Financial Officer of Nostrum Pharmaceuticals and its various subsidiaries. Prior to joining Nostrum, Mr. Grainer served as the Chief Financial Officer of Chatterjee Asset Management (2007-2015), President and Chief Financial Officer of Greenshift Corporation (2004-2007), Managing Director at Zanett Securities (2001-2004) and Managing Director of Prudential Securities (1993-2001).